Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03102905
Other study ID # PI2016_843_0017
Secondary ID
Status Recruiting
Phase N/A
First received March 31, 2017
Last updated March 31, 2017
Start date December 13, 2016
Est. completion date June 13, 2017

Study information

Verified date March 2017
Source Centre Hospitalier Universitaire, Amiens
Contact Guillaume CHABY, Dr
Phone +33322455846
Email chaby.guillaume@chu-amiens.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To look for the replication of HHV6 by PCR in the skin, in these patients with haemopathies presenting an exanthema. This will make it possible to evaluate the prevalence of the positivity of this PCR in the skin. Then the investigator can investigate whether there is an association between the positivity of HHV6 PCR in the blood and / or skin and the viral etiology of the exanthema. If this association exists, it will make it possible to improve the diagnosis in the context of the exanthema and thus to improve the therapeutic management of these patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date June 13, 2017
Est. primary completion date June 13, 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Supported for any type of hemopathy.

- Allograft, autografted or ungrafted haematopoietic stem cells

- Having presented an exanthema during hospitalization, for which a cutaneous biopsy had been performed

- Having had a blood test of the HHV6 virus by PCR at least within the previous 40 days or following the rash.

- Age greater than or equal to 18 years

- Patient informed of the protocol by post, not having refused within one month of sending the said courier.

Exclusion Criteria:

- Patient who refused the search.

- Patient whose HHV6 PCR in the blood was carried out at a distance of more than 40 days from the skin biopsy.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Measurement of the prevalence of the positivity of cutaneous HHV6 quantitative PCR in the cohort studied.
To evaluate the prevalence of the positivity of HHV6 PCR in the skin, during the exanthema in patients hospitalized for haemopathy.

Locations

Country Name City State
France CHU Amiens Picardie Amiens Picardie

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of the prevalence of the positivity of cutaneous HHV6 quantitative PCR in the cohort studied. 1 day
See also
  Status Clinical Trial Phase
Terminated NCT02751112 - Evaluation of a Kit for the Prediction of the Risk of Graft Versus Host Disease N/A
Completed NCT02065297 - Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Recruiting NCT02260739 - Sequential Analysis in Patients With an Hemopathy N/A
Not yet recruiting NCT06369389 - Real-life Management of Patients Eligible for CAR-T Cell Therapy